Search & Analyze
Popular Searches
Aarti Pharmalabs Ltd.
Healthcare₹674.252.20%
24 Jul, 4:01 PM
CMP₹674.25
Mkt Cap₹5.98K Cr
P/E34.24
P/B2.82
ROE14.55%
52W High₹952.00
52W Low₹583.85
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
34.24
P/B Ratio
2.82
EV/EBITDA
17.57
Price/Sales
3.29
Dividend Yield (%)
0.53
EPS (TTM ₹)
19.27
Book Value (₹)
234.30
ROE (%)
14.55
ROCE (%)
17.59
ROA (%)
9.93
EBITDA Margin (%)
21.96
Net Profit Margin (%)
12.88
Debt/Equity
0.20
Current Ratio
2.01
Interest Coverage
14.41
Asset Turnover
0.77
Working Capital/Sales
3.18
Core EBITDA Growth (%)
21.37
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | — | 119994.31 | 194523.28 | 185260.93 | 211507.45 |
| Net Sales | 0 | 119994.31 | 194523.28 | 185260.93 | 211507.45 |
| Total Income | 0 | 120413.22 | 194755.04 | 185750.44 | 212519.37 |
| Total Expenditure | 0.46 | 99467.45 | 160318.13 | 146656.24 | 165070.38 |
| Operating Profit | -0.46 | 20945.77 | 34436.91 | 39094.2 | 47448.99 |
| Depreciation | — | 4211.86 | 6254.27 | 7323.53 | 8690.4 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | -0.46 | 15538.04 | 26077.47 | 30049.2 | 36068.95 |
| Tax | — | 3312.93 | 6728.13 | 8358.99 | 8828.47 |
| Profit After Tax (PAT) | -0.46 | 12225.11 | 19349.34 | 21690.21 | 27240.48 |
| EPS (₹) | -0.18 | 13.49 | 21.35 | 23.93 | 30.06 |
| Dividend Payout % | — | — | 40 | 60 | 100 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 25 | 25 | 4531.3 | 4531.3 | 4531.73 |
| Reserves | -2.19 | 134091.5 | 151317.36 | 171149.78 | 194285.86 |
| Shareholders Funds | 22.81 | 138647.8 | 155848.66 | 175703.92 | 198990.64 |
| Total Debt | 1.73 | 33862.38 | 21433.61 | 26410.35 | 39635.23 |
| Total Liabilities | 25 | 203989.98 | 224402.39 | 258210.5 | 290640.51 |
| Total Assets | 25 | 203989.98 | 224402.39 | 258210.5 | 290640.51 |
| Book Value / Share | 9.124 | 53646.6 | 171.969 | 193.8528 | 219.3617 |
| Assets | 25 | 203989.98 | 224402.39 | 258210.5 | 290640.51 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | — | -4370.38 | 25011.54 | 21635.46 | 33156.15 |
| Investing Activities | — | -13873.89 | -15780.3 | -21456.44 | -41389.77 |
| Financing Activities | — | 26038.5 | -16346.46 | 972.35 | 6543.5 |
| Net Cash Flow | 0 | 7794.23 | -7115.22 | 1151.37 | -1690.12 |
AARTIPHARM
₹674.25
+2.2%